Stem cells are the body's raw materials—cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells become either new stem cells or specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells, or bone cells. No other cell in the body has the natural ability to generate new cell types. Stem cells may one day be used to make cells and tissues for the therapy of many diseases. Examples include Parkinson's disease, Alzheimer's disease, spinal cord injury, heart disease, diabetes, and arthritis. Stem cells are different from other cells in the body in three ways:
- Stem cells can divide and renew itself over a long period of time
- Stem cells are unspecialized, so it cannot do specific functions in the body
- Stem cells have the potential to become specialized cells, such as muscle cells, blood cells, and brain cells
Market Dynamics
Increasing research and development activities conducted by researchers in science institutes are contributing to the growth of the global stem cells market. For instance, in August 2022, scientists from the Weizmann Institute of Science, a public research university in Rehovot, Israel, successfully generated living, growing mouse embryos complete with organ progenitors from stem cells alone—and they did it entirely ex utero, keeping them alive for eight days with the aid of an artificial womb that previously maintained harvested embryos until they were 11 days old.
Key features of the study:
- This report provides an in-depth analysis of the global stem cells market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global stem cells market based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Biotricity, Lineage Cell Therapeutics, Inc., BrainStorm Cell Limited., CIRM, Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company), Takara Bio Inc., Cellular Engineering Technologies., Cytori Therapeutics Inc., STEMCELL Technologies.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cells market.
Detailed Segmentation:
- Global Stem Cells Market, By Type:
- Adult Stem Cells
- Human Embryonic Stem Cells
- Induced Pluripotent Stem Cells
- Natural Rosette Cells
- Very Small Embryonic Like Stem Cells
- Global Stem Cells Market, By Application:
- Regenerative Medicine
- Drug Discovery and Development
- Global Stem Cells Market, By Technology:
- Cell Acquisition
- Cell Production
- Cryopreservation
- Expansion and Sub-Culture
- Global Stem Cells Market, By Region:
- North America
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Advanced Cell Technology, Inc.
- Angel Biotechnology Holdings PLC
- Biotricity
- Lineage Cell Therapeutics, Inc.
- BrainStorm Cell Limited.
- CIRM
- Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company)
- Takara Bio Inc.
- Cellular Engineering Technologies.
- Cytori Therapeutics Inc.
- STEMCELL Technologies
